These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 15136794

  • 1. Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers.
    Gould TD, Quiroz JA, Singh J, Zarate CA, Manji HK.
    Mol Psychiatry; 2004 Aug; 9(8):734-55. PubMed ID: 15136794
    [Abstract] [Full Text] [Related]

  • 2. Emerging experimental therapeutics for bipolar disorder: clues from the molecular pathophysiology.
    Quiroz JA, Singh J, Gould TD, Denicoff KD, Zarate CA, Manji HK.
    Mol Psychiatry; 2004 Aug; 9(8):756-76. PubMed ID: 15136795
    [Abstract] [Full Text] [Related]

  • 3. Treatment of bipolar disorder: new perspectives.
    Alda M, Hajek T, Calkin C, O'Donovan C.
    Ann Med; 2009 Aug; 41(3):186-96. PubMed ID: 18821183
    [Abstract] [Full Text] [Related]

  • 4. Mood stabilizers and atypical antipsychotics: bimodal treatments for bipolar disorder.
    Ketter TA, Nasrallah HA, Fagiolini A.
    Psychopharmacol Bull; 2006 Aug; 39(1):120-46. PubMed ID: 17065977
    [Abstract] [Full Text] [Related]

  • 5. Mood-stabilizing drugs: are their neuroprotective aspects clinically relevant?
    Lagace DC, Eisch AJ.
    Psychiatr Clin North Am; 2005 Jun; 28(2):399-414. PubMed ID: 15826739
    [Abstract] [Full Text] [Related]

  • 6. Molecular effects of lithium.
    Quiroz JA, Gould TD, Manji HK.
    Mol Interv; 2004 Oct; 4(5):259-72. PubMed ID: 15471909
    [Abstract] [Full Text] [Related]

  • 7. Bipolar disorder: leads from the molecular and cellular mechanisms of action of mood stabilizers.
    Manji HK, Moore GJ, Chen G.
    Br J Psychiatry Suppl; 2001 Jun; 41():s107-19. PubMed ID: 11450170
    [Abstract] [Full Text] [Related]

  • 8. The extracellular signal-regulated kinase pathway: an emerging promising target for mood stabilizers.
    Chen G, Manji HK.
    Curr Opin Psychiatry; 2006 May; 19(3):313-23. PubMed ID: 16612219
    [Abstract] [Full Text] [Related]

  • 9. Treatment-refractory bipolar disorder: classification to aid in clinical management.
    Gajwani P.
    Expert Opin Pharmacother; 2009 Aug; 10(12):1907-15. PubMed ID: 19606936
    [Abstract] [Full Text] [Related]

  • 10. [Predictors of prophylactic response to lithium].
    Rohayem J, Baylé JF, Richa S.
    Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
    [Abstract] [Full Text] [Related]

  • 11. Treatments for late-life bipolar disorder.
    Aziz R, Lorberg B, Tampi RR.
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
    [Abstract] [Full Text] [Related]

  • 12. [Possible involvement of protein kinase C in the pathophysiology and treatment of bipolar disorder].
    Einat H, Chen G, Manji H.
    Harefuah; 2004 Jun; 143(6):420-5, 462. PubMed ID: 15524099
    [Abstract] [Full Text] [Related]

  • 13. Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge.
    Rybakowski JK.
    CNS Drugs; 2013 Mar; 27(3):165-73. PubMed ID: 23378337
    [Abstract] [Full Text] [Related]

  • 14. Kinases as drug targets in the treatment of bipolar disorder.
    Catapano LA, Manji HK.
    Drug Discov Today; 2008 Apr; 13(7-8):295-302. PubMed ID: 18405841
    [Abstract] [Full Text] [Related]

  • 15. Antimanic therapies target brain arachidonic acid signaling: lessons learned about the regulation of brain fatty acid metabolism.
    Lee HJ, Rao JS, Rapoport SI, Bazinet RP.
    Prostaglandins Leukot Essent Fatty Acids; 2007 Apr; 77(5-6):239-46. PubMed ID: 18042366
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Glycogen synthase kinase-3: a target for novel bipolar disorder treatments.
    Gould TD, Zarate CA, Manji HK.
    J Clin Psychiatry; 2004 Jan; 65(1):10-21. PubMed ID: 14744163
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Lithium: bipolar disorder and neurodegenerative diseases Possible cellular mechanisms of the therapeutic effects of lithium.
    Marmol F.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec 12; 32(8):1761-71. PubMed ID: 18789369
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.